| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Director
2 companies
Ajer Jeffrey Robert is an EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $6.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2020 | NKTR Nektar Therapeutics | Director | Sell | 2,250 | $19.74 | $44,415.00 | -10.1% | |
| Jun 19, 2020 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sale+OE | 15,000 | $124.00 | $1,860,000.00 | -19.1% | |
| Apr 8, 2020 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 2,407 | $79.98 | $192,511.86 | -3.7% | |
| Apr 1, 2020 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,537 | $82.00 | $126,034.00 | -2.3% | |
| Mar 25, 2020 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 3,659 | $76.18 | $278,733.22 | -2.6% | |
| Sep 30, 2019 | NKTR Nektar Therapeutics | Director | Sell | 2,375 | $18.06 | $42,892.50 | -9.6% | |
| Sep 20, 2019 | NKTR Nektar Therapeutics | Director | Sell | 2,250 | $20.24 | $45,540.00 | -11.0% | |
| Mar 26, 2019 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 3,656 | $89.18 | $326,024.90 | -7.2% | |
| Mar 21, 2019 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 4,519 | $89.98 | $406,633.95 | -3.9% | |
| Mar 19, 2019 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 3,728 | $93.07 | $346,964.96 | -5.9% |